In October 2025, the FDA released a revised guidance titled, “Expanded Access to Investigational Drugs for Treatment Use—Questions and Answers.” ...
The FDA encourages sponsors to discuss plans to use animal testing alternatives, called new approach methodologies or NAMs, ...
Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...
In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...
In its latest PFDD installment, the FDA offers a detailed roadmap for sponsors seeking to design, adapt, or validate COAs that accurately ...
Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from ...
The Well News on MSN
FDA Draft Guidance Places New Limits on Toxicity Tests Involving Primates
WASHINGTON - The Food and Drug Administration released a draft guidance on Tuesday significantly reducing the range of ...
The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...
Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to vaccine ...
For certain monospecific antibodies, three-month toxicology studies plus other supportive evidence will suffice, eliminating ...
A dozen former leaders of the U.S. Food and Drug Administration (FDA) slammed the Trump administration Wednesday over its ...
Scholars argue that federal drug agency actions should take precedence over conflicting state regulations. How should courts handle state regulations that restrict access to pharmaceuticals previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results